Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

BOPA/ISOPP 2019 | Audit of rapid infusion of biosimilar rituximab

Calum Polwart • 10 Oct 2019
BOPA/ISOPP 2019
Rituximab

Calum Polwart, County Durham & Darlington NHS Foundation Trust, Durham, UK, discusses his work on a multi-center audit of the rapid infusion of biosimilar rituximab in patients with hematological malignancies. This interview took place at the International Society of Oncology Pharmacy Practitioners (ISOPP) Symposium 2019, hosted by the British Oncology Pharmacy Association (BOPA), held in London, UK.

More from Calum Polwart

Dose banding in oncology
2:29
Dose banding in oncology
Calum Polwart • 10 Oct 2019
How to achieve an outstanding clinical pharmacy service
2:17
How to achieve an outstanding clinical pharmacy service
Calum Polwart • 13 Oct 2018

Choose your cookie settings

VJOncology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJOncology is intended for healthcare professionals